| Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization G D’Amato, ST Holgate, R Pawankar, DK Ledford, L Cecchi, M Al-Ahmad, ... World allergy organization journal 8, 1-52, 2015 | 570 | 2015 |
| The global burden of chronic urticaria for the patient and society M Gonçalo, A Gimenéz‐Arnau, M Al‐Ahmad, M Ben‐Shoshan, ... British Journal of Dermatology 184 (2), 226-236, 2021 | 221 | 2021 |
| Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement J Bousquet, CA Akdis, M Jutel, C Bachert, L Klimek, I Agache, ... Allergy 75 (10), 2440-2444, 2020 | 198 | 2020 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 165 | 2020 |
| Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement ML Kowalski, I Ansotegui, W Aberer, M Al-Ahmad, M Akdis, ... World Allergy Organization Journal 9, 1-42, 2016 | 164 | 2016 |
| Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort LG Heaney, LP de Llano, M Al-Ahmad, V Backer, J Busby, GW Canonica, ... Chest 160 (3), 814-830, 2021 | 163 | 2021 |
| Handling of allergen immunotherapy in the COVID‐19 pandemic: an ARIA‐EAACI statement L Klimek, M Jutel, C Akdis, J Bousquet, M Akdis, C Bachert, I Agache, ... Allergy 75 (7), 1546-1554, 2020 | 145 | 2020 |
| Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 129 | 2021 |
| Defining a severe asthma super-responder: findings from a Delphi process JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021 | 99 | 2021 |
| Type 2 inflammation in asthma and other airway diseases J Maspero, Y Adir, M Al-Ahmad, CA Celis-Preciado, FD Colodenco, ... ERJ Open Research 8 (3), 2022 | 94 | 2022 |
| Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper A Barbaud, LH Garvey, A Arcolaci, K Brockow, F Mori, C Mayorga, ... Allergy 77 (8), 2292-2312, 2022 | 80 | 2022 |
| Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies J Bousquet, JP Cristol, W Czarlewski, JM Anto, A Martineau, T Haahtela, ... Clinical and translational allergy 10 (1), 58, 2020 | 80 | 2020 |
| The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria E Kocatürk, A Salman, I Cherrez‐Ojeda, PR Criado, J Peter, ... Allergy, 2020 | 73 | 2020 |
| Potential severe asthma hidden in UK primary care D Ryan, H Heatley, LG Heaney, DJ Jackson, PE Pfeffer, J Busby, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (4), 1612-1623. e9, 2021 | 57 | 2021 |
| Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies F Musa, M Al-Ahmad, N Arifhodzic, W Al-Herz Human vaccines & immunotherapeutics 13 (3), 514-517, 2017 | 57 | 2017 |
| Real world biologic use and switch patterns in severe asthma: data from the international severe asthma registry and the US CHRONICLE study AN Menzies-Gow, C McBrien, B Unni, CM Porsbjerg, M Al-Ahmad, ... Journal of asthma and allergy, 63-78, 2022 | 55 | 2022 |
| Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model C Incorvaia, M Al‐Ahmad, IJ Ansotegui, S Arasi, C Bachert, C Bos, ... Allergy 76 (4), 1041-1052, 2021 | 44 | 2021 |
| Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. World Allergy Organ J … G D’Amato, ST Holgate, R Pawankar, DK Ledford, L Cecchi, M Al-Ahmad, ... dx. doi. org/10.1186/s40413-015-0073-0, 0 | 40 | |
| ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy J Bousquet, O Pfaar, I Agache, A Bedbrook, CA Akdis, GW Canonica, ... Clinical and translational allergy 11 (4), e12014, 2021 | 37 | 2021 |
| Omalizumab therapy in three patients with chronic autoimmune urticaria M Al-Ahmad Annals of Saudi medicine 30 (6), 478-481, 2010 | 37 | 2010 |
Edin Jusufovic; MD, pulmonologist; Ms...Medical School of University in TuzlaVerified email at untz.ba
